EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK

Victoria Hamill, Will Gelson, Douglas MacDonald, Paul Richardson, Stephen D Ryder, Mark Aldersley, Stuart McPherson iD, Sumita Verma iD, Rohini Sharma iD, Sharon Hutchinson, Jennifer Benselin, Eleanor Barnes und 3 weitere

Liver International · 2023

DOI: 10.1111/liv.15528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Victoria Hamill und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis C, Hepatitis C, Chronic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, MRF_.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies show the uptake of biannual ultrasound (US) surveillance in patients with cirrhosis is suboptimal. Here, our goal was to understand in broader terms how surveillance is being delivered to cirrhosis patients with cured hepatitis C in the UK.

Methods

Hepatitis C cirrhosis patients achieving a sustained viral response (SVR) to antiviral therapies were identified from the national Hepatitis‐C‐Research‐UK resource. Data on (i) liver/abdominal US examinations, (ii) HCC diagnoses, and (iii) HCC curative treatment were obtained through record‐linkage to national health registries. The rate of US uptake was calculated by dividing the number of US episodes by follow‐up time.

Results

A total of 1908 cirrhosis patients from 31 liver centres were followed for 3.8 (IQR: 3.4–4.9) years. Overall, 10 396 liver/abdominal USs were identified. The proportion with biannual US was 19% in the first 3 years after SVR and 9% for all follow‐up years. Higher uptake of biannual US was associated with attending a liver transplant centre; older age and cirrhosis decompensation. Funnel plot analysis indicated significant inter‐centre variability in biannual US uptake, with 6/29 centres outside control limits. Incident HCC occurred in 133 patients, of which 49/133 (37%) were treated with curative intent. The number of US episodes in the two years prior to HCC diagnosis was significantly associated with higher odds of curative‐intent treatment (aOR: 1.53; 95% CI: 1.12–2,09; p = .007).

Conclusions

This study provides novel data on the cascade of care for HCC in the UK. Our findings suggest biannual US is poorly targeted, inefficient and is not being delivered equitably to all patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis CHepatitis C, ChronicHumansLiver CirrhosisHepacivirusUnited KingdomAntiviral AgentsSustained Virologic Response

Stichwörter der Autor:innen

adherenceimagingliver cancerscreeningultrasonography

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
  • Public Health Scotland, Glasgow, UK.
  • Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Gastroenteology and Hepatology, Royal Free London NHS Foundation Trust, London, UK.
  • Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  • NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, UK.

ORCID-Profile: Stuart McPherson, Sumita Verma, Rohini Sharma, Hamish Innes

Förderung

  • Cancer Research UK
  • Medical Research Council
  • MRF_
  • Medical Research Foundation

Zitieren

APA

Hamill, V., Gelson, W., MacDonald, D., Richardson, P., Ryder, S. D., Aldersley, M., McPherson, S., Verma, S., Sharma, R., Hutchinson, S., Benselin, J., Barnes, E., Guha, I. N., Irving, W. L., & Innes, H. (2023). Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK. Liver International. https://doi.org/10.1111/liv.15528

Vancouver

Hamill V, Gelson W, MacDonald D, Richardson P, Ryder SD, Aldersley M, et al. Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK. Liver International. 2023. doi:10.1111/liv.15528

BibTeX
@article{Hamill2023,
  author = {Hamill, Victoria and Gelson, Will and MacDonald, Douglas and Richardson, Paul and Ryder, Stephen D and Aldersley, Mark and McPherson, Stuart and Verma, Sumita and Sharma, Rohini and Hutchinson, Sharon and Benselin, Jennifer and Barnes, Eleanor and Guha, Indra Neil and Irving, William L and Innes, Hamish},
  title = {Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK},
  journal = {Liver International},
  year = {2023},
  doi = {10.1111/liv.15528}
}
Kostenlos starten →